Our results are in accordance with this study since we observed that low FAK levels were significantly associated with the absence of response (minimal and poor response) to neoadjuvant CRT treatment supporting that FAK loss induces radio‐resistance in rectal cancer patients and it could be a potential predictive marker. Here, PTK2 is linked to rectal cancer.